CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- 4 Open-market buy CFO and Treasurer bought 100 shares at $7.49 ($749)
- 4 Open-market buy Chief Executive Officer bought 1,000 shares at an average $7.30 ($7,300)
- S-1 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Bylaws or fiscal year change · Other events
- 4 Conversion Director acquired 166,667 shares (conversion)
- 4 Conversion Director acquired 166,667 shares (conversion)
- 4 Conversion Director acquired 25,000 shares (conversion)
- 4 Conversion Director acquired 166,667 shares (conversion)
- 4 Conversion CFO and Treasurer acquired 37,500 shares (conversion)
- 4 Conversion Director acquired 166,667 shares (conversion)
- 4 Conversion See Remarks acquired 37,500 shares (conversion)
- 8-K Event Shareholder vote results
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- DEF 14A Proxy Proxy Statement
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
Page 70 of 76 · 1,519 filings